These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35839756)

  • 21. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 22. SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand.
    Jairak W; Chamsai E; Udom K; Charoenkul K; Chaiyawong S; Techakriengkrai N; Tangwangvivat R; Suwannakarn K; Amonsin A
    Sci Rep; 2022 May; 12(1):8403. PubMed ID: 35589808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular detection of SARS-CoV-2 and differentiation of Omicron and Delta variant strains.
    Tsui WNT; Hamill V; Noll L; Lu N; Porter EP; Harbidge D; Cox E; Richardson C; Gray M; Sebhatu T; Goerl K; Brown S; Hanzlicek G; Retallick J; Bai J
    Transbound Emerg Dis; 2022 Sep; 69(5):e1618-e1631. PubMed ID: 35218683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan.
    Shy CG; Lu JH; Lin HC; Hung MN; Chang HC; Lu ML; Chao HR; Chen YS; Wang PS
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural infection of Delta mutant of SARS-CoV-2 in Asiatic lions of India.
    Karikalan M; Chander V; Mahajan S; Deol P; Agrawal RK; Nandi S; Rai SK; Mathur A; Pawde A; Singh KP; Sharma GK
    Transbound Emerg Dis; 2022 Sep; 69(5):3047-3055. PubMed ID: 34404118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.].
    Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI
    Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.
    Lundberg AL; Lorenzo-Redondo R; Hultquist JF; Hawkins CA; Ozer EA; Welch SB; Prasad PVV; Achenbach CJ; White JI; Oehmke JF; Murphy RL; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37377. PubMed ID: 35500140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June-July 2021.
    Dale AP; Almendares O; Howard BJ; Burnett E; Prasai S; Arons M; Collins J; Duffy N; Pandit U; Brady S; White JR; Garrett B; Kirking HL; Sunenshine R; Tate JE; Scott SE
    Clin Infect Dis; 2022 Aug; 75(1):e20-e26. PubMed ID: 35413107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity.
    Pierobon A; Zotto AD; Antico A; De Antoni ME; Vianello L; Gennari M; Di Caprio A; Russo F; Brambilla G; Saugo M
    Clin Microbiol Infect; 2022 Apr; 28(4):614.e5-614.e7. PubMed ID: 34958917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector.
    Zhang Y; Wen J; Li X; Li G
    Infect Genet Evol; 2021 Sep; 93():104933. PubMed ID: 34023511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.
    Akaishi T; Ishii T
    J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients.
    Alotaibi B; El-Masry TA; Seadawy MG; El-Harty BE; Saleh A; Gad AF; El-Hosseny MF; Mahran YF; El-Bouseary MM
    Infect Genet Evol; 2022 Jun; 100():105278. PubMed ID: 35367360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 cold-chain transmission: Characteristics, risks, and strategies.
    Chen C; Feng Y; Chen Z; Xia Y; Zhao X; Wang J; Nie K; Niu P; Han J; Xu W
    J Med Virol; 2022 Aug; 94(8):3540-3547. PubMed ID: 35355277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.